NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
Back to search
Official data from USPTO
AMERIPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/11/2024
Trademark type
Combined
Nice classes
5, 35
Filing date
07/20/2022
Registration date
06/11/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
02/07/2013
First use in commerce
02/07/2013
Drawing code
3
Owner type
03
Owner location
ORANGE, CA
Examiner
REAMS, CHRISTOPHER
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a horizontal DNA double helix created with the use of dots, connected by straight lines that lead into and surround the first two letters of AmeriPharma which is written in standard font.
Holders and representatives
Holders
Harper's Pharmacy, Inc.
Representatives
Gor Mnatsakanyan
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders
Class 35
Mail order pharmacy services; Retail pharmacy services
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2024
PUBO
PUBLISHED FOR OPPOSITION
03/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/16/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/03/2023
GNFR
FINAL REFUSAL E-MAILED
11/03/2023
CNFR
FINAL REFUSAL WRITTEN
11/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/29/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/29/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2023
GNRT
NON-FINAL ACTION E-MAILED
04/08/2023
CNRT
NON-FINAL ACTION WRITTEN
04/08/2023
DOCK
ASSIGNED TO EXAMINER
03/29/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2022
NWAP
NEW APPLICATION ENTERED
07/23/2022
Continuous trademark protection
Get notified about every new filing that threatens AMERIPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.